Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer. - Lebok P; Huber J; Burandt EC; Lebeau A; Marx AH; Terracciano L; Heilenkötter U; Jänicke F; Müller V; Paluchowski P; Geist S; Wilke C; et al. (Molecular medicine reports, 2016)